Literature DB >> 14616237

Redox regulation of the afferent arteriole and tubuloglomerular feedback.

C S Wilcox1.   

Abstract

Oxidative stress implies an increased production of reactive oxygen species (ROS) or a decreased capacity to metabolize them. Superoxide anion (O) can bioinactivate nitric oxide (NO). Therefore, many effects of ROS are manifest as NO deficiency. The afferent arteriole and macula densa cell both contain a full complement of components of nicotine adenine dinucleotide phosphate (NADPH) oxidase that generates O. Nitric oxide synthase (NOS) type 1 or neuronal NOS (nNOS) is expressed in the macula densa and NOS type II or endothelial NOS (eNOS) in the afferent arteriole. Whole animal studies in models of hypertension and oxidative stress demonstrate that metabolism of O by a superoxide dismutase (SOD) mimetic can reduce renal vascular resistance. In vivo studies of single nephron function and in vitro studies with the double-perfused juxtaglomerular apparatus preparation have shown extensive interaction between O and NO in macula densa to regulate afferent arteriolar tone mediated by the tubuloglomerular feedback response. In vitro studies of rabbits isolated, perfused afferent arterioles have shown a similar interaction in this vessel. These data indicate important roles for O in the macula densa and afferent arterioles to enhance preglomerular resistance in animal models of oxidative stress. As an increase in afferent arteriolar resistance can precede hypertension, oxidative stress could be important in determining the long-term blood pressure and thereby contribute to hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616237     DOI: 10.1046/j.0001-6772.2003.01205.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  27 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability.

Authors:  Mattias Carlström; En Yin Lai; Zufu Ma; Andreas Steege; Andreas Patzak; Ulf J Eriksson; Jon O Lundberg; Christopher S Wilcox; A Erik G Persson
Journal:  Hypertension       Date:  2010-09-27       Impact factor: 10.190

Review 3.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

Review 4.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

Review 5.  Purinoceptors, renal microvascular function and hypertension.

Authors:  Z Guan; M N Makled; E W Inscho
Journal:  Physiol Res       Date:  2020-04-17       Impact factor: 1.881

Review 6.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

7.  Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling.

Authors:  Timothy R Nurkiewicz; Dale W Porter; Ann F Hubbs; Samuel Stone; Bean T Chen; David G Frazer; Matthew A Boegehold; Vincent Castranova
Journal:  Toxicol Sci       Date:  2009-03-06       Impact factor: 4.849

Review 8.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

9.  Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.

Authors:  Helmy M Siragy; Jiqian Huang
Journal:  Exp Physiol       Date:  2008-01-11       Impact factor: 2.969

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.